HAP / VAP

>

Latest News

Decreasing Ventilator-Associated Pneumonia With Novel Oral Care Program
Decreasing Ventilator-Associated Pneumonia With Novel Oral Care Program

June 29th 2021

A significant decrease in the rate of VAP occurred during the study period.

FDA Approves Imipenem-Cilastatin and Relebactam for HABP/VABP
FDA Approves Imipenem-Cilastatin and Relebactam for HABP/VABP

June 5th 2020

The Benefits of Dual Therapy for Gram-Negative Infections: An Assessment of the Guidelines
The Benefits of Dual Therapy for Gram-Negative Infections: An Assessment of the Guidelines

October 7th 2018

Non-ventilator Hospital-acquired Pneumonia: An Emerging Threat
Non-ventilator Hospital-acquired Pneumonia: An Emerging Threat

January 16th 2018

Is it Time to Give Inhaled Antibiotics Another Chance?
Is it Time to Give Inhaled Antibiotics Another Chance?

August 22nd 2017

Video Interviews

More News

© 2024 MJH Life Sciences

All rights reserved.